Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment
- PMID: 20141248
- PMCID: PMC3703617
- DOI: 10.1037/a0017550
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment
Abstract
Polymorphisms of the mu-opioid receptor (OPRM1) and dopamine D4 receptor (DRD4) genes are associated with subjective responses to alcohol and urge to drink under laboratory conditions. This study examined these associations in the natural environment using ecological momentary assessment. Participants were non-treatment-seeking heavy drinkers (n = 112, 52% female, 61% alcohol dependent) who enrolled in a study of naltrexone effects on craving and drinking in the natural environment. Data were culled from 5 consecutive days of drinking reports prior to medication randomization. Analyses revealed that, after drinking, carriers of the Asp40 allele of the OPRM1 gene reported higher overall levels of vigor and lower levels negative mood, as compared to homozygotes for the Asn40 variant. Carriers of the long allele (i.e., >or=7 tandem repeats) of the DRD4 endorsed greater urge to drink than homozygotes for the short allele. Effects of OPRM1 and DRD4 variable-number-of-tandem-repeats genotypes appear to be alcohol dose-dependent. Specifically, carriers of the DRD4-L allele reported slight decreases in urge to drink at higher levels of estimated blood alcohol concentration (eBAC), and Asp40 carriers reported decreases in vigor and increases in negative mood as eBAC rose, as compared to carriers of the major allele for each gene. Self-reported vigor and urge to drink were positively associated with alcohol consumption within the same drinking episode. This study extends findings on subjective intoxication, urge to drink, and their genetic bases from controlled laboratory to naturalistic settings.
Figures



Similar articles
-
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.Alcohol Clin Exp Res. 2008 Jan;32(1):58-66. doi: 10.1111/j.1530-0277.2007.00545.x. Epub 2007 Nov 20. Alcohol Clin Exp Res. 2008. PMID: 18028530 Free PMC article.
-
Genetic moderators of naltrexone's effects on alcohol cue reactivity.Alcohol Clin Exp Res. 2006 Aug;30(8):1288-96. doi: 10.1111/j.1530-0277.2006.00156.x. Alcohol Clin Exp Res. 2006. PMID: 16899031 Clinical Trial.
-
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.Alcohol Clin Exp Res. 2012 Nov;36(11):2000-7. doi: 10.1111/j.1530-0277.2012.01807.x. Epub 2012 May 2. Alcohol Clin Exp Res. 2012. PMID: 22551036 Free PMC article. Clinical Trial.
-
Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.Addiction. 2020 Aug;115(8):1426-1437. doi: 10.1111/add.14975. Epub 2020 Feb 11. Addiction. 2020. PMID: 31961981 Free PMC article.
-
Pharmacogenetics of alcohol and alcohol dependence treatment.Curr Pharm Des. 2010;16(19):2141-8. doi: 10.2174/138161210791516387. Curr Pharm Des. 2010. PMID: 20482509 Free PMC article. Review.
Cited by
-
Using Ecological Momentary Assessment (EMA) to Study Sex Events Among Very High-Risk Men Who Have Sex with Men (MSM).AIDS Behav. 2016 Oct;20(10):2231-2242. doi: 10.1007/s10461-015-1272-y. AIDS Behav. 2016. PMID: 26746212 Free PMC article.
-
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.Alcohol Clin Exp Res. 2012 Mar;36(3):385-94. doi: 10.1111/j.1530-0277.2011.01633.x. Epub 2011 Sep 6. Alcohol Clin Exp Res. 2012. PMID: 21895723 Free PMC article. Review.
-
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.Alcohol Clin Exp Res (Hoboken). 2023 Sep;47(9):1629-1645. doi: 10.1111/acer.15143. Epub 2023 Jul 23. Alcohol Clin Exp Res (Hoboken). 2023. PMID: 37423771 Free PMC article. Review.
-
Pharmacogenetically driven treatments for alcoholism: are we there yet?CNS Drugs. 2012 Jun 1;26(6):461-76. doi: 10.2165/11633180-000000000-00000. CNS Drugs. 2012. PMID: 22587755 Free PMC article. Review.
-
Alcohol demand as a predictor of drinking behavior in the natural environment.Addiction. 2022 Jul;117(7):1887-1896. doi: 10.1111/add.15822. Epub 2022 Feb 16. Addiction. 2022. PMID: 35112741 Free PMC article.
References
-
- Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry. 2008;65(2):135–144. - PMC - PubMed
-
- Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology. 2004;173:32–40. - PubMed
-
- Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine receptor variants. Journal of Neurochemistry. 1995;65:1157–1165. - PubMed
-
- Asghari V, Schoots O, van Kats S, Ohara K, Jovanovic V, Guan HC, Bunzow JR, Petronis A, Van Tol HH. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Molecular Pharmacology. 1994;46:364–373. - PubMed
-
- Arias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug and Alcohol Dependence. 2006;83:262–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials